Your browser doesn't support javascript.
loading
The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials.
Barker, Timothy Hugh; Stone, Jennifer C; Sears, Kim; Klugar, Miloslav; Tufanaru, Catalin; Leonardi-Bee, Jo; Aromataris, Edoardo; Munn, Zachary.
Afiliação
  • Barker TH; JBI, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.
  • Stone JC; JBI, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.
  • Sears K; Queen's Collaboration for Health Care Quality, Queen's University, Kingston, ON, Canada.
  • Klugar M; Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, The Czech Republic (Middle European) Centre for Evidence-Based Healthcare: A JBI Centre of Excellence, Masaryk University GRADE Centre), Faculty of Medicine, Institute of Biostatistics and Analyse
  • Tufanaru C; Centre for Health Informatics, Australian Institute of Health Innovation, Macquarie University, Sydney, NSW, Australia.
  • Leonardi-Bee J; The Nottingham Centre for Evidence Based Healthcare: A JBI Centre of Excellence, School of Medicine, University of Nottingham, Nottingham, UK.
  • Aromataris E; JBI, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.
  • Munn Z; JBI, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.
JBI Evid Synth ; 21(3): 494-506, 2023 03 01.
Article em En | MEDLINE | ID: mdl-36727247
ABSTRACT
JBI recently began the process of updating and revising its suite of critical appraisal tools to ensure that these tools remain compatible with recent developments within risk of bias science. Following a rigorous development process led by the JBI Effectiveness Methodology Group, this paper presents the revised critical appraisal tool for the assessment of risk of bias for randomized controlled trials. This paper also presents practical guidance on how the questions of this tool are to be interpreted and applied by systematic reviewers, while providing topical examples. We also discuss the major changes made to this tool compared to the previous version and justification for why these changes facilitate best-practice methodologies in this field.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ensaios Clínicos Controlados Aleatórios como Assunto Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ensaios Clínicos Controlados Aleatórios como Assunto Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article